AEPCX
Price
$58.16
Change
+$0.03 (+0.05%)
Updated
Jun 5 closing price
Net Assets
133.45B
MIOLX
Price
$29.11
Change
+$0.05 (+0.17%)
Updated
Jun 5 closing price
Net Assets
804.04M
Interact to see
Advertisement

AEPCX vs MIOLX

Header iconAEPCX vs MIOLX Comparison
Open Charts AEPCX vs MIOLXBanner chart's image
American Funds EUPAC C
Price$58.16
Change+$0.03 (+0.05%)
VolumeN/A
Net Assets133.45B
Morgan Stanley Inst International Opp L
Price$29.11
Change+$0.05 (+0.17%)
VolumeN/A
Net Assets804.04M
AEPCX vs MIOLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. MIOLX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and MIOLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. MIOLX (804M). AEPCX pays higher dividends than MIOLX: AEPCX (0.32) vs MIOLX (0.00). AEPCX was incepted earlier than MIOLX: AEPCX (24 years) vs MIOLX (15 years). MIOLX (3.02) is less costly to investors than AEPCX (1.59). AEPCX is a more actively managed with annual turnover of: 30.00 vs. MIOLX (28.00). AEPCX has a lower initial minimum investment than MIOLX: AEPCX (250) vs MIOLX (1000). MIOLX annual gain was more profitable for investors over the last year : 22.36 vs. AEPCX (2.04). AEPCX return over 5 years is better than : 14.22 vs. MIOLX (6.52).
AEPCXMIOLXAEPCX / MIOLX
Total Expense Ratio1.591.8586%
Annual Report Gross Expense Ratio1.593.0253%
Fund Existence24 years15 years-
Gain YTD12.50213.51693%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets133B804M16,542%
Annual Yield % from dividends0.320.00-
Returns for 1 year2.0422.369%
Returns for 3 years14.8233.3045%
Returns for 5 years14.226.52218%
Returns for 10 years20.6787.3624%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNN30.301.03
+3.52%
Smith & Nephew plc
APLS19.100.59
+3.19%
Apellis Pharmaceuticals
CATO2.63-0.01
-0.38%
CATO Corp
STOK10.86-0.08
-0.73%
Stoke Therapeutics
GRI1.39-0.06
-4.14%
GRI Bio Inc.